Scholarlink

<p>Actin-Related Protein Complex 1B (ARPC1B) is a subunit of the ARP2/3 complex that is predominately expressed in hematopoietic cells and is involved in the regulation of actin polymerization. ARPC1B deficiency leads to combined immunodeficiency (CID) with symptoms of eczema, allergies, inflammation, recurrent infection, and thrombocytopenia. We characterize the disease-causing variant c.899_944del (p.E300Gfs*7) on the <i>ARPC1B</i> gene that originated from a founder effect in an indigenous American population. We showed that this variant impairs protein expression leading to a complete deficiency of ARPC1B. Additionally, we used mass cytometry to thoroughly analyze the effects of this mutation on the frequencies of immune populations. Our findings suggest that ARPC1B is critical for class switching since our ARPC1B-deficient patient had reduced frequencies of class-switched memory B cells. Furthermore, the frequencies of total CD4<sup>+</sup>, CD8<sup>+</sup>, and γδ T cells were reduced, consistent with an essential function of ARPC1B in T cell development. Overall, this study advances the knowledge of the c.899_944del <i>ARPC1B</i> mutation and the understanding of the role of ARPC1B in the immune system.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Molecular analysis and immunological characterization of a founder mutation causing ARPC1B deficiency

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月17日

查看全文
  • Megan M. Dobrose,
  • Meltem Ece Kars,
  • Jareb J. Perez-Caraballo,
  • Colleen M. Roark,
  • Christine Mariskanish,
  • Oscar Zavaleta-Martinez,
  • Noemi Gomez-Hernandez,
  • Saul Oswaldo Lugo-Reyes,
  • Yuval Itan,
  • Lizbeth Blancas-Galicia,
  • Rubén Martínez-Barricarte

摘要

Actin-Related Protein Complex 1B (ARPC1B) is a subunit of the ARP2/3 complex that is predominately expressed in hematopoietic cells and is involved in the regulation of actin polymerization. ARPC1B deficiency leads to combined immunodeficiency (CID) with symptoms of eczema, allergies, inflammation, recurrent infection, and thrombocytopenia. We characterize the disease-causing variant c.899_944del (p.E300Gfs*7) on the ARPC1B gene that originated from a founder effect in an indigenous American population. We showed that this variant impairs protein expression leading to a complete deficiency of ARPC1B. Additionally, we used mass cytometry to thoroughly analyze the effects of this mutation on the frequencies of immune populations. Our findings suggest that ARPC1B is critical for class switching since our ARPC1B-deficient patient had reduced frequencies of class-switched memory B cells. Furthermore, the frequencies of total CD4+, CD8+, and γδ T cells were reduced, consistent with an essential function of ARPC1B in T cell development. Overall, this study advances the knowledge of the c.899_944del ARPC1B mutation and the understanding of the role of ARPC1B in the immune system.